KPKessara Pathanapitoon

Kessara Pathanapitoon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kessara Pathanapitoon has a total of 553 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Repeatability and Reproducibility of an Automated Image-Processing Software for Quantitative Conjunctival Hyperemia Analysis: A Pilot Study

    by Linda Hansapinyo, Kessara Pathanapitoon, Napaporn Tananuvat, Winai Chaidaroon, Somsanguan Ausayakhun, Pichaya Kulniwatcharoen, Nathaya Panyowatkul, Timothy E. O’BRien, Karn Patanukhom

    OBJECTIVE Conjunctival hyperemia reflects the severity of various ocular conditions and is a common side effect of glaucoma medications, posing a significant concern for affected patients. Most existing clinical grading systems are subjective and rely heavily on individual physician interpretation, making interobserver comparison difficult. We developed an automated grading software to objectively and quantitatively assess conjunctival hyperemia. This study aimed to evaluate the repeatability and reproducibility of a newly developed automated software for quantitative assessment of conjunctival hyperemia in glaucoma patients in a pilot validation study. METHODS In this pilot study, glaucoma patients using at least one topical anti-glaucoma medication and exhibiting conjunctival hyperemia were enrolled. Each patient’s conjunctival hyperemia was assessed using the automated software, which segmented images into four regions: blood vessel area, strong red area, weak red area, and non-red area. An automatic region of interest (ROI) registration function was incorporated to enhance measurement consistency. Repeatability was assessed using two measurements from the same image, and reproducibility was tested using separate images of the same eye. RESULTS Eighty images from twenty glaucoma patients were analyzed (collected between December 1, 2016, and December 31, 2018). Following administration of 10% phenylephrine ophthalmic solution, the percentage of conjunctival hyperemia decreased significantly in all regions (p < 0.001). Spearman correlation coefficients for repeated measurements on the same image were 0.884 (blood vessel), 0.982 (strong red), and 0.932 (weak red). Corresponding values for repeated images of the same eye were 0.988, 0.992, and 0.995, respectively. The intraclass correlation coefficient (ICC) for clinical grading by ten ophthalmologists was 0.969 (95% CI: 0.952–0.981). CONCLUSION This pilot study demonstrates that the proposed automated software provides an objective and quantitative assessment of conjunctival hyperemia with excellent repeatability and reproducibility. The system shows high correlation with clinical grading and may serve as a reliable tool for monitoring conjunctival hyperemia changes in clinical practice.


  • Open Access

    Interferon-gamma autoantibodies in patients with infectious uveitis: a pilot case–control study

    by Apichaya Opasatian, Chatchai Tayapiwatana, Weeraya Thongkum, Umpa Yasamut, Kessara Pathanapitoon

    To investigate the association between infectious uveitis in immunocompetent individuals and adult-onset immunodeficiency (AOID). A pilot prospective obser

  • Open Access

    Comparative biocompatibility of hydrophilic vs. hydrophobic intraocular lenses following phacoemulsification in patients with uveitis

    by Atitaya Apivatthakakul, Apichat Tantraworasin, Paradee Kunavisarut, Kessara Pathanapitoon

    Purpose: To evaluate and compare the biocompatibility of hydrophilic and hydrophobic intraocular lenses (IOLs) in patients with uveitis undergoing phacoemulsification, with particular focus on posterior capsule opacification (PCO), postoperative inflammation, and visual outcomes. Methods: Patients with uveitis who underwent phacoemulsification with IOL implantation between 2015 and 2023 were retrospectively reviewed. Propensity score matching (1:1) was performed to account for clinical and demographic variables, yielding 132 eyes (66 per group) for analysis. Primary outcomes included the incidence of PCO and the need for neodymium-doped yttrium aluminum garnet (Nd:YAG) laser capsulotomy. Secondary outcomes were the rate of uveitis reactivation and visual improvement. Cox regression models were used to estimate adjusted hazard ratios (HRs) with 95% confidence intervals (CIs). Results: Hydrophobic IOLs were significantly associated with a reduced risk of PCO (adjusted HR = 0.35; 95% CI, 0.18–0.68; p < 0.05) and Nd:YAG capsulotomy (adjusted HR = 0.23; 95% CI, 0.09–0.56; p < 0.05) compared to hydrophilic IOLs. No significant difference was found in the rate of uveitis reactivation between groups (adjusted HR = 0.83; 95% CI, 0.37–1.88; p = 0.643). Conclusion: Hydrophobic intraocular lenses show better capsular biocompatibility in uveitic eyes by significantly reducing the incidence of PCO and need for Nd:YAG capsulotomy, without increasing postoperative inflammation. These findings support the preferential use of hydrophobic acrylic IOLs in cataract surgery for patients with uveitis.


  • Open Access

    Prevalence and Risk Factors for Ocular Complications in New-Onset Uveitis: A Study From a Tertiary Referral Center in Northern Thailand

    by Atitaya Apivatthakakul, Apichat Tantraworasin, Aniki Rothova, Paradee Kunavisarut, Kessara Pathanapitoon

    Purpose: To determine the prevalence and identify risk factors of ocular complications in patients with uveitis. Methods: This retrospective study reviewed of 340 consecutive patients with a first episode of active uveitis from January 2015 to December 2019. Demographic and clinical data, including ocular complications were analyzed. Results: The mean age of the cohort was 47 years. Among them, 75 patients were HIV-positive (74% male), and 265 were HIV-negative (53% male). An Infectious etiology was identified in 52% of cases. Ocular complications, developed in 151 patients (44%), with their type strongly correlate to the anatomical location of uveitis. Multivariate analysis revealed chronic inflammation (risk ratio [RR]=18.9; 95% confidence interval [CI] 6.1– 58.8), recurrent inflammation (RR=20.4; 95%; CI 6.5– 64.3), and poor visual acuity (VA) at presentation (RR=3.6; 95% CI 1.4– 9.2) as significant risk factors for complications. Conclusion: Nearly half of the patients with uveitis developed ocular complications, highlighting the importance of identifying risk factors. Understanding the relationship between the location of inflammation and specific complication patterns is essential for early detection and targeted prevention strategies.


  • Open Access

    Clinical Characteristics and Outcomes of Primary Vitreoretinal Lymphoma in Northern Thailand

    by Pantaree Choosri, Kessara Pathanapitoon, Paradee Kunavisarut, Janejit Choovuthayakorn, Atitaya Apivatthakakul, Pichaya Kulniwatcharoen, Aniki Rothova

    OBJECTIVE This study aims to describe clinical characteristics and outcomes after treatment of primary vitreoretinal lymphoma (PVRL). METHODS Fifteen patients with a proven diagnosis of PVRL by histology, cytology and/or flow cytometry were analyzed. RESULTS The median age of the 15 patients was 59 years (range 41-71). Median follow-up time was 37 months (IQR 22.5-80) (range 4-106). Ophthalmic presentations of 25 eyes included vitritis (72%), chorioretinal infiltrations (60%), and retinal vasculitis (20%). Bilateral involvement was observed in 10 patients at presentation and in 4 patients during follow up. Ten patients (67%) developed brain involvement after ocular presentation with a median time of 22.5 months (range 2-84). Treatment modalities were included: 1) isolated intravitreal (IVT) methotrexate (6/15 patients; 40%) with a median number of injections of 4 (IQR 1,6) (range 1-16) 2) combined with IVT metho-trexate and/or rituximab and systemic chemotherapy and/or radiation (8/15; 53%) with a median of 6 injections (IQR 1,11) (range 1-16) and 3) systemic chemotherapy alone (1/15; 7%). Whole brain radiotherapy (WBRT) was performed in 10 of 15 patients (67%). Among the 6 patients who received isolated IVT methotrexate, 3 patients had complete remission (3/6; 50%), one died at 96 months after treatment, and one was lost to follow up after a single injection. Nine of 15 patients who received systemic chemotherapy with or without IVT chemotherapy and/or WBRT had complete remission (8/9; 89%). CONCLUSIONS Vitritis and chorioretinal infiltrations were the main ocular presentations of PVRL. Two-thirds of the patients developed brain involvement which resolved after treatment. Systemic chemotherapy tends to provide a higher rate of complete remission compared to local therapy alone.

  • Clinical and Microbiological Manifestations of Endogenous Endophthalmitis in Tertiary Care Hospital, Northern Thailand

    by Paradee Kunavisarut, Pavinee Tangkitchot, Janejit Choovuthayakorn, Direk Patikulsila, Nawat Watanachai, Voraporn Chaikitmongkol, Kessara Pathanapitoon, Aniki Rothova

    To determine the characteristics, primary sources, pathogens, risk factors, and visual outcomes in patients with endogenous endophthalmitis (EE).We performed a retrospective cohort study of 61 cons...


  • Open Access

    Repeatability and Reproducibility of Automated Quantitative Conjunctival Hyperemia Analysis Software (Preprint)

    by Linda Hansapinyo, Kessara Pathanapitoon, Napaporn Tananuvat, Winai Chaidaroon, Somsanguan Ausayakhun, Pichaya Kulniwatcharoen, Nathaya Panyowatkul, Timothy E O’brien, Karn Patanukhom

    BACKGROUND The degree of conjunctival hyperemia reflects the severity of various ocular disease. Most of clinical grading systems rely on individual physicians and it is difficult to compare between clinical examinations. We developed automated grading software to objectively assess conjunctival hyperemia. OBJECTIVE To assess the repeatability and reproducibility of newly developed automated quantitative conjunctival hyperemia analysis software. METHODS Eighty images of twenty glaucoma patients who were using at least one anti-glaucoma medication and complained of conjunctival hyperemia were collected. All patients’ severity of conjunctival hyperemia was evaluated by newly developed automated conjunctival hyperemia grading software into 4 levels: blood vessel, strong red area, weak red area and non-red area. Automatic registration was applied for improving the software repeatability and reproducibility. RESULTS Spearman correlation coefficient values(rs) values of 0.884, 0.982 and 0.932 for blood vessel area, strong red area and weak red area of two measurements of the same image, respectively. Spearman correlation coefficient (rs) values of 0.988, 0.992 and 0.995 for blood vessel area, strong red area and weak red area of two images of the same eye, respectively. The clinical grading had the best correlation with the summation of blood vessel and strong red area, following with strong red area. CONCLUSIONS The proposed conjunctival hyperemia analysis software provides an automatically quantitative objective assessment of conjunctival hyperemia with excellent repeatability and reproducibility including excellent correlation with clinical grading by ophthalmologists. This algorithm including the automatic region of interest (ROI) registration between two images system give precise results in comparing the conjunctival hyperemic change in clinical practice.

  • The Presence of Pigmentation on Central Anterior Lens Capsule in the Human Leukocyte Antigen B27-Associated Anterior Uveitis and Its Value in Clinical Diagnosis

    by Napassiri Sujaritputangoon, Janejit Choovuthayakorn, Paradee Kunavisarut, Aniki Rothova, Phichayut Phinyo, Vorapat Muangsuwan, Panisara Wongpanya, Duanpen Narongjunchai, Kessara Pathanapitoon

    To report on the value of presence of pigmentation on central anterior lens capsule (PioLe) in HLA B27- associated anterior uveitis (HLA B27-AU).268 patients (320 eyes) with AU were reviewed. Two d...


  • Open Access

    Idiopathic Epiretinal Membranes: Visual Outcomes and Prognostic Factors

    by Paradee Kunavisarut, Montana Supawongwattana, Direk Patikulsila, Janejit Choovuthayakorn, Nawat Watanachai, Voraporn Chaikitmongkol, Kessara Pathanapitoon, Aniki Rothova

    İdiyopatik Epiretinal Membranlar: Görme Sonuçları ve Prognostik Faktörler


  • Case Report: Bilateral Granulomatous Anterior Uveitis in HIV-patient with Disseminated Talaromycosis (penicilliosis) Marneffei Infection

    by Chansathya Khieu, Atitaya Apivatthakakul, Paradee Kunavisarut, Kessara Pathanapitoon

    We report on a 22-years-old Thai male patient with congenital HIV infection. Due to his non-adherence to antiretroviral treatment he developed disseminated Talaromyces marneffei infection and was treated with intravenous amphotericin B. Despite this treatment, he presented with bilateral granulomatous anterior uveitis. Uveitis improved only after intracameral injection of amphotericin B.